Mohammed bin Zayed
Mohammed bin Zayed

His Highness Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces, issued new orders to pay for the treatment of critical cases of coronavirus "Covid-19" through stem cells.

In a related context, His Highness’s initiative comes after the recent announcement by the Abu Dhabi Stem Cell Center to enable him to reach this auxiliary treatment and the success of the treatment experience in the country in seventy-three cases where she recovered and the result of the negative test appeared after the treatment was introduced into the lungs through inhalation by a fine mist.

In this regard, the initiative aims to promote and encourage medical research to develop supportive treatment for people infected with the "emerging corona virus" with human and technical capabilities, and to provide its requirements and technologies, and facilitate its generalization procedures for all state hospitals.

On the other hand, it aims to treat stem cells .. the critical cases where this treatment reflects in addition to the medical measures taken .. concerted efforts and the United Arab Emirates endeavor to contribute to ending the epidemic of Corona Virus / Covid - 19 /.

On the other hand, the Abu Dhabi Stem Cell Center had revealed that it could reach this supportive treatment, as it helps patients overcome the symptoms caused by the emerging corona virus, but it does not eliminate the virus itself.

At the present time, it includes extracting stem cells from the patient's blood and re-entering them after their activation. The treatment was tried in the country in many cases where it recovered, and the result of the examination appeared negative after the introduction of the treatment to the lungs through inhalation by a fine spray.

The therapeutic effect of all those infected with coronaviruses in the UAE aims to regenerate lung cells, adjust their immune response, to prevent them from overreacting to "Covid 19" infection, and causing damage to more healthy cells.

It should be noted that the treatment was provided to patients in conjunction with traditional medical intervention and will continue to be applied as a support to the treatment protocols in place and not as a substitute for them.